iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/23770291
Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Oct;25(10):1939-48.
doi: 10.1016/j.cellsig.2013.06.007. Epub 2013 Jun 11.

Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders

Anu Kauppinen  1 , Tiina Suuronen, Johanna Ojala, Kai Kaarniranta, Antero Salminen
Affiliations
Review

Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders

Anu Kauppinen et al. Cell Signal. 2013 Oct.

Abstract

Recent studies have indicated that the regulation of innate immunity and energy metabolism are connected together through an antagonistic crosstalk between NF-κB and SIRT1 signaling pathways. NF-κB signaling has a major role in innate immunity defense while SIRT1 regulates the oxidative respiration and cellular survival. However, NF-κB signaling can stimulate glycolytic energy flux during acute inflammation, whereas SIRT1 activation inhibits NF-κB signaling and enhances oxidative metabolism and the resolution of inflammation. SIRT1 inhibits NF-κB signaling directly by deacetylating the p65 subunit of NF-κB complex. SIRT1 stimulates oxidative energy production via the activation of AMPK, PPARα and PGC-1α and simultaneously, these factors inhibit NF-κB signaling and suppress inflammation. On the other hand, NF-κB signaling down-regulates SIRT1 activity through the expression of miR-34a, IFNγ, and reactive oxygen species. The inhibition of SIRT1 disrupts oxidative energy metabolism and stimulates the NF-κB-induced inflammatory responses present in many chronic metabolic and age-related diseases. We will examine the molecular mechanisms of the antagonistic signaling between NF-κB and SIRT1 and describe how this crosstalk controls inflammatory process and energy metabolism. In addition, we will discuss how disturbances in this signaling crosstalk induce the appearance of chronic inflammation in metabolic diseases.

Keywords: AGRP; AMP-activated protein kinase; AMPK; AP-1; Aging; B-cell lymphoma/leukemia-10; BCL10; CIITA; DHA; E2F1; EPA; ERK; Forkhead box O protein; FoxO; GAPDH; HIC1; HIF; IAP-2; IFN-γ; IKK; IL; Inflammation; IκBα; JAK; Janus kinase; LKB1; LPS; M1; M2; MCP-1; Metabolic disease; NAD; NAMPT; NF-κB; NLR; NOS; PARP-1; PDK4; PGC-1α; PHD; PPAR; ROS; SF1; SIRT1; STAT; SUMO; TGFβ; TLR; TNFα; Toll-like receptor; UTR; activator protein-1; agouti-related protein; alternatively activated anti-inflammatory macrophage; class II, major histocompatibility complex, transactivator; classically activated proinflammatory macrophage; docosahexaenoic acid; eicosapentaenoic acid; extracellular signal-regulated kinase; glyceraldehyde 3-phosphate dehydrogenase; hypermethylated in cancer-1; hypoxia-inducible factor; inhibitor of apoptosis-2; inhibitor of κB protein-α; inhibitory-κB kinase; interferon-γ; interleukin; lipopolysaccharide; miR; microRNAs; monocyte chemotactic protein-1; nicotinamide adenine dinucleotide; nicotinamide mononucleotide adenylyltransferase; nitric oxide synthase; nuclear factor-κB; nucleotide-binding domain leucine-rich repeat-containing receptor; peroxisome proliferator-activated receptor; peroxisome proliferator-activated receptor-γ coactivator-1α; poly(ADP-ribose) polymerase-1; prolyl-hydroxylase domain-containing protein; pyruvate dehydrogenase kinase 4; reactive oxygen species; serine/threonine kinase 11; signal transducer and activator of transcription; silent information regulator 1; small ubiquitin-like modifier; steroidogenic factor 1; transcription factor E2F1; transforming growth factor β; tumor necrosis factor-α; untranslated region.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

LinkOut - more resources